Programmed death-ligand 1: Difference between revisions
Jump to navigation
Jump to search
m →General: replace template/fix ref |
|||
| Line 37: | Line 37: | ||
==Drugs - Immune checkpoint inhibitors== | ==Drugs - Immune checkpoint inhibitors== | ||
*PD-1 inhibitors: | *PD-1 inhibitors: | ||
**Nivolumab | **Nivolumab (Opdivo, Bristol-Myers Squibb). | ||
**Pembrolizumab | **Pembrolizumab (Keytruda, Merck). | ||
*PD-L1 inhibitors: | *PD-L1 inhibitors: | ||